"Viral Plaque Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.
| Descriptor ID |
D010948
|
| MeSH Number(s) |
E01.370.225.875.970.790 E05.200.875.970.790
|
| Concept/Terms |
Viral Plaque Assay- Viral Plaque Assay
- Assay, Viral Plaque
- Assays, Viral Plaque
- Plaque Assay, Viral
- Plaque Assays, Viral
- Viral Plaque Assays
Bacteriophage Plaque Assay- Bacteriophage Plaque Assay
- Assay, Bacteriophage Plaque
- Assays, Bacteriophage Plaque
- Bacteriophage Plaque Assays
- Plaque Assay, Bacteriophage
- Plaque Assays, Bacteriophage
|
Below are MeSH descriptors whose meaning is more general than "Viral Plaque Assay".
Below are MeSH descriptors whose meaning is more specific than "Viral Plaque Assay".
This graph shows the total number of publications written about "Viral Plaque Assay" by people in this website by year, and whether "Viral Plaque Assay" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Viral Plaque Assay" by people in Profiles.
-
Comparison of plaque- and enzyme-linked immunospot-based assays to measure the neutralizing activities of monoclonal antibodies specific to domain III of dengue virus envelope protein. Clin Vaccine Immunol. 2012 Jan; 19(1):73-8.
-
Light-independent inactivation of dengue-2 virus by carboxyfullerene C3 isomer. Virology. 2000 Sep 30; 275(2):258-62.
-
Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer. Prostate. 1999 Sep 15; 41(1):31-8.
-
Serologic and mucosal immune response to rotavirus infection in the rabbit model. J Virol. 1991 May; 65(5):2562-71.
-
A Vh region synthetic peptide induces antibodies which bind native immunoglobulins and augment an immune response to antigen. Adv Exp Med Biol. 1989; 251:129-43.
-
The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles. J Virol. 1988 Nov; 62(11):4403-6.
-
Non-targeted mutagenesis of unirradiated lambda phage in Escherichia coli host cells irradiated with ultraviolet light. J Mol Biol. 1984 Mar 05; 173(3):293-305.
-
Identification of rotaviruses of different origins by the plaque-reduction test. Am J Vet Res. 1980 Jan; 41(1):151-2.
-
A plaque assay for the simian rotavirus SAII. J Gen Virol. 1979 Jun; 43(3):513-9.